The Fitful Path Of Progress In Science: Set Back By Prematurity, Spurred By Creativity

Most scientists--including me--hold to the idea that there is a "real world" out there and that experimental and observational science, objectively interpreted, is gradually unveiling a true picture of it. Impressed by the power of modern research tools and by superbly trained leaders of research, one is tempted to perceive the rapid advance of the natural sciences as smooth paths, ever more closely approximating a complete and correct understanding of the natural world. Fortunately, the actu

Written byOtto Landman
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Fortunately, the actual picture has been less predictable--and more interesting. Newton's universe was deconstructed and reconstructed by Einstein; Einstein's picture of the universe, in turn, is being extended by black holes, pulsars, and cosmic strings.

Darwin's world has been deconstructed and reconstructed by the neo-Darwinists, but their authority is now being called into question by neutral evolution, the selfish gene, punctuated equilibria, saltation, and horizontal gene flow. The path to truth is beset by partial truths. Scientists must try to avoid entrapment by partial truths--to have their thinking circumscribed by current orthodoxies.

Why do scientists find it difficult to liberate their thinking from current orthodoxies? This question was examined most perceptively by Gunther Stent in a December 1972 article in Scientific American (227[6]:84-93) entitled "Prematurity and Uniqueness in Scientific Discovery." Citing a series of cases in which important scientific discoveries were initially ignored, only to be rediscovered later, Stent concludes ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies